Structural Formula (Image 1)
Buspirone Hydrochloride Tablet
Product Images NDC 71335-2510
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 71335-2510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
10 mg (one-third Of A Tablet) (Image 10)
Break Tablet 30 mg (Image 11)
15 mg (the Entire Tablet) (Image 2)
10 mg (two-thirds Of A Tablet) (Image 3)
7.5 mg (one-half Of A Tablet) (Image 4)
5 mg (one-third Of A Tablet) (Image 5)
Break Tablet 15 mg (Image 6)
30 mg (the Entire Tablet) (Image 7)
20 mg (two-thirds Of A Tablet) (Image 8)
15 mg (one-half Of A Tablet) (Image 9)
Label (Lbl713352510)
This is a package insert for Buspirone Hydrochloride tablets, USP 30 mg. It provides information on dosing, storage instructions, and a link to access the Patient Package Inserts. The tablets are to be kept out of reach of children and stored at 20° to 25°C (68° to 77°F), with excursions permitted from 15° to 30°C (59° to 86°F). The medication should be dispensed in a tight, light-resistant container with a child-resistant closure. The tablets were repackaged by Bryant Ranch Prepack, Inc. and manufactured by Teva Pharmaceuticals USA, Inc. It is intended for prescription use only and comes in a pack of 60 tablets. The provided NDC code is 71335-2510-1.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
